“Morphine – do it yourself” an opportunity and a threat for the sick – Polish Radio

                             

                                 
 
 05/14/2015
 
                             

                                 
 
 
 
     
      0
 
 
     
      0
 
 
     
     
 
 
 
 
 
 
 

– In Poland there is space for a refund and we really want to refund medication effective for all patients who need them. We invite manufacturers to cooperate – says Igor Radziewicz-Vinnytsia Photo: picture illustration / Pixabay / Public domain

                         
                     

                             Antibiotics again in the spotlight of world experts. In their view, they need two billions of dollars in new research in this field.
                         

                                           
                                             Listen
                                           
                                         
                                     

                                                    
                                                 00’48
 
                                                     
                                                         Antibiotics – a new fund? – Raphael Motriuk / IAR
                                                     
                                                 
                                                    
                                                                                            

Doctors have long alarm: the lack of new antibiotics, and more and more bacteria – from tuberculosis to typhoid fever – stops responding to traditional antibiotics.

That’s why a team of experts appointed by the British government calls for the pharmaceutical industry pay into a special fund two billion US dollars. The money would get scientists and small biotech companies.

Then those who would produce new antibiotics, would receive guaranteed payout. According to British experts, could thus create 15 new antibiotics within a decade. Today, large pharmaceutical companies are doing this reluctantly, because the financial risk is enormous. According to the head of the British team, economist Jim O’Neil, drug-resistant bacteria can kill in the middle of the century ten million people every year.

(IAR)